Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/10/2025

Diagnosis and Management of Aspergillus Infection

Introduction to Aspergillus Infection

  • The European Respiratory Society recommends that Aspergillus isolated from BAL fluid be treated as clinically significant, particularly when combined with compatible clinical and radiological findings 1

Key Distinction: BAL vs. Sputum

  • The European Respiratory Society states that BAL specimens have high specificity for Aspergillus infection, whereas sputum is less specific due to the ubiquitous nature of the fungus 1

Enhancing Diagnostic Certainty

  • The European Respiratory Society suggests that multiple factors, including colony count and antibody testing, increase the likelihood that BAL Aspergillus represents true infection rather than contamination 1
  • The presence of anti-Aspergillus antibodies has a 100% positive predictive value for detecting infection, according to the European Respiratory Society 1, 3
  • BAL galactomannan testing has a sensitivity of 77-86% and specificity of 76-77% for detecting Aspergillus infection, as reported by the European Respiratory Society 1, 3

Clinical Context Interpretation

  • In immunocompromised patients, any Aspergillus from BAL should be considered highly significant for invasive aspergillosis, according to the European Society of Clinical Microbiology and Infectious Diseases 2, 4
  • In patients with chronic lung disease, BAL Aspergillus combined with positive serology confirms chronic pulmonary aspergillosis rather than colonization, as stated by the European Respiratory Society 1, 3

Diagnostic Algorithm

  • Obtaining Aspergillus IgG antibodies or precipitins can confirm infection with 100% positive predictive value, according to the European Respiratory Society 1, 3
  • Performing BAL galactomannan can support infection diagnosis, with values >0.5 indicating a sensitivity of 77-86% and specificity of 76-77%, as reported by the European Respiratory Society 1, 3
  • Reviewing imaging for signs such as halo sign, air-crescent sign, or cavity formation on CT can help define probable invasive fungal infection, according to the European Society of Clinical Microbiology and Infectious Diseases 2, 5

Common Pitfalls

  • The European Respiratory Society advises against dismissing positive BAL cultures as "just colonization" and recommends thorough evaluation 1
  • The European Society of Clinical Microbiology and Infectious Diseases warns against relying on culture alone in patients on antifungal prophylaxis, suggesting the use of galactomannan or PCR instead 2, 6